Brief: Orgenesis Received Approval From Regulators To Continue Working In Co's Research And Development Labs During Pandemic
30/03/2020 12:39
March 30 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS INC - RECEIVED APPROVAL FROM REGULATORS TO
CONTINUE
WORKING IN CO'S RESEARCH AND DEVELOPMENT LABS DURING PANDEMIC
Source text for Eikon: ID:nGNXbp9jJ6
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules